Alpine Immune Sciences, Inc. (ALPN) Stock Overview
Explore Alpine Immune Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Alpine Immune Sciences, Inc. (ALPN)
Key Financials
Key Financials
Market Cap
4.5B
P/E Ratio
-101.52
EPS (TTM)
$-0.64
ROE
-0.13%
ALPN Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Alpine Immune Sciences, Inc. (NASDAQ: ALPN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Alpine Immune Sciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ALPN on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $90.40 for the NASDAQ listing.
Key metrics behind Alpine Immune Sciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -101.52 and a market capitalization of 4.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ALPN on the NASDAQ.